SciClone Pharmaceuticals Inc (SCLN)

11.15
Prev Close 11.15
Day Low/High 11.15 / 11.20
52 Wk Low/High 8.55 / 11.43
Avg Volume 462.50K
Exchange
Shares Outstanding 52.19M
Market Cap 581.94M
EPS 0.60
Div & Yield N.A. (N.A)
SciClone Pharmaceuticals (SCLN) Flagged As Strong On High Volume

SciClone Pharmaceuticals (SCLN) Flagged As Strong On High Volume

Trade-Ideas LLC identified SciClone Pharmaceuticals (SCLN) as a strong on high relative volume candidate

SciClone Pharmaceuticals is Now Oversold (SCLN)

SciClone Pharmaceuticals is Now Oversold (SCLN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Commit To Purchase SciClone Pharmaceuticals At $7.50, Earn 14% Annualized Using Options

Commit To Purchase SciClone Pharmaceuticals At $7.50, Earn 14% Annualized Using Options

Investors considering a purchase of SciClone Pharmaceuticals, Inc. shares, but cautious about paying the going market price of $8.50/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BECN, EGT, EMKR, LDR, PAR Downgrades: CIA, CJJD, CNP, ENDP, EVTC, FLR, FPRX, FRED, NTAP, OLED, SCLN, SLAB, XON, ZGNX Initiations: LMCK, LPG Read on to get TheStreet Quant Ratings' detailed report:

SciClone Pharmaceuticals (SCLN) Stock: Weak On High Volume Today

SciClone Pharmaceuticals (SCLN) Stock: Weak On High Volume Today

Trade-Ideas LLC identified SciClone Pharmaceuticals (SCLN) as a weak on high relative volume candidate

Trade-Ideas: SciClone Pharmaceuticals (SCLN) Is Today's Weak On High Relative Volume Stock

Trade-Ideas: SciClone Pharmaceuticals (SCLN) Is Today's Weak On High Relative Volume Stock

Trade-Ideas LLC identified SciClone Pharmaceuticals (SCLN) as a weak on high relative volume candidate

Trade-Ideas: SciClone Pharmaceuticals (SCLN) Is Today's Strong On High Relative Volume Stock

Trade-Ideas: SciClone Pharmaceuticals (SCLN) Is Today's Strong On High Relative Volume Stock

Trade-Ideas LLC identified SciClone Pharmaceuticals (SCLN) as a strong on high relative volume candidate

SciClone Pharmaceuticals (SCLN) Strong On High Relative Volume Today

SciClone Pharmaceuticals (SCLN) Strong On High Relative Volume Today

Trade-Ideas LLC identified SciClone Pharmaceuticals (SCLN) as a strong on high relative volume candidate

Buy These 6 Risky Pharmaceutical Stocks for Big Upside Potential

Buy These 6 Risky Pharmaceutical Stocks for Big Upside Potential

Looking to add even more performance to your portfolio? Consider pharmaceutical stocks with so-called high beta - a common measurement of volatility.

Insider Trading Alert - SANW, STRZA And SCLN Traded By Insiders

Insider Trading Alert - SANW, STRZA And SCLN Traded By Insiders

Stocks with insider trader activity include SANW, STRZA and SCLN

Strong On High Relative Volume: SciClone Pharmaceuticals (SCLN)

Strong On High Relative Volume: SciClone Pharmaceuticals (SCLN)

Trade-Ideas LLC identified SciClone Pharmaceuticals (SCLN) as a strong on high relative volume candidate

SciClone Pharmaceuticals (SCLN): Today's Weak On High Volume Stock

SciClone Pharmaceuticals (SCLN): Today's Weak On High Volume Stock

Trade-Ideas LLC identified SciClone Pharmaceuticals (SCLN) as a weak on high relative volume candidate

Commit To Buy SciClone Pharmaceuticals At $7.50, Earn 10.2% Annualized Using Options

Commit To Buy SciClone Pharmaceuticals At $7.50, Earn 10.2% Annualized Using Options

Investors considering a purchase of SciClone Pharmaceuticals, Inc. stock, but cautious about paying the going market price of $8.92/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Insider Trading Alert - JAZZ, ARE And SCLN Traded By Insiders

Insider Trading Alert - JAZZ, ARE And SCLN Traded By Insiders

Stocks with insider trader activity include JAZZ, ARE and SCLN

Rules of the Game: Healthcare Hangs Tough

Hospitals, biotechs and drug makers continue to hold their own.

SCLN: Insiders vs. Shorts

SCLN: Insiders vs. Shorts

The most recent short interest data was recently released by the NASDAQ for the 07/31/2014 settlement date, and SciClone Pharmaceuticals, Inc. is one of the most shorted stocks of the Russell 3000, based on 20.92 "days to cover" versus the median component at 6.30.

Ratings Changes Today

Upgrades: BREW, CRMT, EGY, HNRG, OSUR, SCLN, TC Downgrades: LSCC, NAT, REXX, VLCCF Initiations: BLUE, HMTV, NDLS Read on to get TheStreet Quant Ratings' detailed report:

SciClone Pharmaceuticals Stock Downgraded (SCLN)

SciClone Pharmaceuticals Stock Downgraded (SCLN)

SciClone Pharmaceuticals (Nasdaq:SCLN) has been downgraded by TheStreet Ratings from from a buy to hold.

Ratings Changes Today

Upgrades: AXAS, DEPO, GIGM, IRDM, MAG, MTRN, NWN, XLS Downgrades: CLGX, DDD, GKNT, HMIN, SCLN, VII Initiations: CNOB Read on to get TheStreet Quant Ratings' detailed report:

First Week of February 22nd Options Trading For SciClone Pharmaceuticals (SCLN)

First Week of February 22nd Options Trading For SciClone Pharmaceuticals (SCLN)

Investors in SciClone Pharmaceuticals, Inc. saw new options become available this week, for the February 22nd expiration.

4 Stocks Under $10 Moving Higher

4 Stocks Under $10 Moving Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Analyst Favorites With Strong Buyback Activity: SciClone Pharmaceuticals Ranks As a Top Pick

Analyst Favorites With Strong Buyback Activity: SciClone Pharmaceuticals Ranks As a Top Pick

A study of analyst recommendations at the major brokerages shows that SciClone Pharmaceuticals, Inc. is the #56 broker analyst pick among those stocks screened by The Online Investor for strong stock buyback activity.

Ratings Changes Today

Upgrades: BMRN, CSPI, DLPH, GSB, QGEN, RCKY, RDEN, SCLN, SGOC, VAC, WOOF Downgrades: ATAX, BONA, CMLP, CRME, EGAS, FORR, FULL, KRNY, PCYG, QSII, VHI Initiations: ALEX, CZR, INSY, LGP, MCBK, USMD, WDAY Read on to get TheStreet Quant Ratings' detailed report:

SciClone Pharmaceuticals Is Now Oversold (SCLN)

SciClone Pharmaceuticals Is Now Oversold (SCLN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

SciClone Pharmaceuticals Becomes Oversold (SCLN)

SciClone Pharmaceuticals Becomes Oversold (SCLN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

SciClone Pharmaceuticals Stock Sees Short Interest Increase 10%

SciClone Pharmaceuticals Stock Sees Short Interest Increase 10%

The most recent short interest data has been released by the NASDAQ for the 08/30/2013 settlement date, which shows a 341,840 share increase in total short interest for SciClone Pharmaceuticals, Inc. , to 3,744,055, an increase of 10.05% since 08/15/2013.

SciClone Pharmaceuticals Stock Downgraded (SCLN)

SciClone Pharmaceuticals Stock Downgraded (SCLN)

SciClone Pharmaceuticals (Nasdaq:SCLN) has been downgraded by TheStreet Ratings from from a buy to hold.

Ratings Changes Today

Upgrades: DIOD, DVR, FXCM, LHCG, LYV, PAR, RVP, USM Downgrades: ACC, AU, DISH, IO, KBR, MG, NWN, RNWK, SCLN Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Commit To Buy SciClone Pharmaceuticals At $5, Earn 14.8% Annualized

Commit To Buy SciClone Pharmaceuticals At $5, Earn 14.8% Annualized

Investors considering a purchase of SciClone Pharmaceuticals, Inc. stock, but tentative about paying the going market price of $5.67/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Healthcare Sector: High Quality Stocks At A Great Value

Healthcare Sector: High Quality Stocks At A Great Value

Nick Sousa, Kapitall:  Analysts are favoring the healthcare sector in 2013 due to strong projected growth supported by an aging [...]